Sub Banner Image

EXCLUSIVE: Envoy Medical Cuts Capital Needs After FDA Approval For Final Trial Stage Of Cochlear Implant Trial

Market Impact

Vandana Singh

·

October 7, 2025

·

Benzinga

Envoy Medical secured FDA approval to expand its Acclaim cochlear implant trial, accelerating timelines and reducing capital needs by up to $15 million.

read more

More from

Benzinga

More

Market Impact

Articles

Trending News

Enjoy premium content in your inbox.

You're in! Check your email to learn more.
Oops! Something went wrong while submitting the form.